Related Experiment Video
Updated: Jan 26, 2026

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017
Oxidation destabilizes toxic amyloid beta peptide aggregation
J Razzokov1, M Yusupov2, A Bogaerts2
1Research Group PLASMANT, Department of Chemistry, University of Antwerp, Universiteitsplein 1, B-2610, Antwerp, Belgium. jamoliddin.razzokov@uantwerpen.be.
Abstract:
The aggregation of insoluble amyloid beta (Aβ) peptides in the brain is known to trigger the onset of neurodegenerative diseases, such as Alzheimer's disease. In spite of the massive number of investigations, the underlying mechanisms to destabilize the Aβ aggregates are still poorly understood. Some studies indicate the importance of oxidation to destabilize the Aβ aggregates. In particular, oxidation induced by cold atmospheric plasma (CAP) has demonstrated promising results in eliminating these toxic aggregates. In this paper, we investigate the effect of oxidation on the stability of an Aβ pentamer. By means of molecular dynamics simulations and umbrella sampling, we elucidate the conformational changes of Aβ pentamer in the presence of oxidized residues, and we estimate the dissociation free energy of the terminal peptide out of the pentamer form. The calculated dissociation free energy of the terminal peptide is also found to decrease with increasing oxidation. This indicates that Aβ pentamer aggregation becomes less favorable upon oxidation. Our study contributes to a better insight in one of the potential mechanisms for inhibition of toxic Aβ peptide aggregation, which is considered to be the main culprit to Alzheimer's disease.
Insights
Oxidation destabilizes amyloid beta (Aβ) pentamers, reducing toxic aggregation linked to Alzheimer's disease. This finding offers insights into potential therapeutic strategies for neurodegenerative disorders.
Area of Science:
- Biochemistry
- Neuroscience
- Computational Chemistry
Background:
- Amyloid beta (Aβ) peptide aggregation in the brain is a hallmark of Alzheimer's disease.
- Mechanisms for destabilizing toxic Aβ aggregates are not fully understood.
- Oxidation, particularly via cold atmospheric plasma (CAP), shows promise in degrading Aβ aggregates.
Purpose of the Study:
- To investigate the impact of oxidation on the stability of Aβ pentamers.
- To elucidate conformational changes in Aβ pentamers with oxidized residues.
- To quantify the effect of oxidation on Aβ pentamer dissociation.
Main Methods:
- Molecular dynamics simulations.
- Umbrella sampling techniques.
- Free energy calculations for peptide dissociation.
Main Results:
- Oxidation induces conformational changes in Aβ pentamers.
- Dissociation free energy of terminal peptides decreases with increased oxidation.
- Oxidation makes Aβ pentamer aggregation less favorable.
Conclusions:
- Oxidation is a viable mechanism for destabilizing toxic Aβ aggregates.
- This study provides insights into inhibiting Aβ aggregation, a key factor in Alzheimer's disease.
- Findings support oxidation-based strategies for Alzheimer's disease treatment.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Destabilization of Microtubules
Drugs that Destabilize Microtubules
Peptide Bonds
Oxidation Numbers

